STOCK TITAN

Codexis to Present at Two Virtual Investment Conferences in September

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Codexis, a leading protein engineering company, announced its participation in two upcoming virtual investment conferences. The first event is the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020, at 10:30 a.m. ET. The second is the Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, 2020, at 8:00 a.m. ET. A live webcast and replay will be available on their Investors website.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at two upcoming virtual investment conferences:

  • H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020 at 10:30 a.m. Eastern time (7:30 a.m. Pacific time).

  • Cantor Fitzgerald Virtual Global Healthcare Conference in a fireside chat format on Thursday, September 17, 2020 at 8:00 a.m. Eastern time (5:00 a.m. Pacific time).

A live webcast and replay of the presentations will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com.

Contact: 

LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com


FAQ

What are the dates and times for Codexis's upcoming investment conferences?

Codexis will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020, at 10:30 a.m. ET and at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, 2020, at 8:00 a.m. ET.

Where can I watch the Codexis conference presentations?

You can watch the live webcast and replay of the Codexis conference presentations on their Investors website.

What is Codexis known for?

Codexis is known for its protein engineering and proprietary CodeEvolver® technology, which is used to develop proteins for various applications, including pharmaceuticals and biocatalytic processes.

What type of company is Codexis?

Codexis is a protein engineering company specializing in biocatalysts for pharmaceutical manufacturing, fine chemicals, industrial enzymes, and more.

Codexis, Inc.

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Stock Data

365.39M
79.57M
2.23%
79.83%
2.4%
Biotechnology
Industrial Organic Chemicals
Link
United States of America
REDWOOD CITY